findmyKOL

Karen Brudney, MD

Basic profile

Vital Strategies

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 1998findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1994–1998Why? →

Karen Brudney is an Infectious Disease physician affiliated with Vital Strategies. OpenAlex indexes 36 publications with 2,345 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
36publications

Distinct works indexed by OpenAlex.

2,345citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1994–1998

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    47.2%
    Protease Inhibitor22.5%
    Ritonavir47%Prezista42%Darunavir5%Prezcobix4%Atazanavir Sulfate3%
    Part D<11 patients
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor8.5%
    Tivicay87%Isentress14%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    36.1%
    Statin11.7%
    Rosuvastatin Calcium75%Pravastatin Sodium18%Atorvastatin Calcium6%
    Part D<11 patients
    ACE inhibitor9.1%
    Lisinopril94%Enalapril Maleate6%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    9.5%
    Biguanide (metformin)5.7%
    Metformin Hcl100%
    Part D15 patients
    Proton pump inhibitor1.5%
    Omeprazole100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19941998 per NIH RePORTER. The latest:

2 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”